Search
  1. Home
  2. Africa
  3. Southern Africa
  • News

India/South Africa cheap AIDS drugs venture announced

    JOHANNESBURG

    Indian drug company Ranbaxy and South Africa's Community Investment Holdings (CIH) have agreed to jointly supply cheaper anti-AIDS drug to three Southern African countries.

    Ranbaxy will hold a 70 percent stake in the joint venture while CIH, which has investments in key areas of technology, logistics and health, will hold the remaining 30 percent.

    In a statement Ranbaxy said high-quality low-cost antiretrovirals (ARVs) would be distributed by governments, aid groups, AIDS management companies and retail pharmacies in South Africa, Botswana and Namibia.

    The Indian drug manufacturer, which has a significant presence in South Africa, has been providing generic ARVs at affordable prices to other developing countries hard-hit by the pandemic.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join